InfuSystem Holdings

INFU · NYSE American

$14.23+$0.49 (+3.57%)TodayMarket closed · Oct 20, 8:00 PM ET

Prev close $13.74

Latest news

Press releaseSep 17, 4:30 PM ETBusiness Wire
InfuSystem to Host Investor Webcast on September 24, 2026
NewsAug 4, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsAug 4, 9:33 AM ET
InfuSystems Holdings Reports Q2 2026 Results: Full Earnings Call Transcript
NewsAug 4, 6:32 AM ET
InfuSystems Holdings Q2 EPS $0.15 Beats $0.11 Estimate, Sales $36.933M Beat $36.353M Estimate
Press releaseAug 4, 6:30 AM ETBusiness Wire
InfuSystem Announces Financial Results for Second Quarter 2026
Press releaseJul 28, 6:30 AM ETBusiness Wire
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
Press releaseMay 18, 4:30 PM ETBusiness Wire
InfuSystem Announces $20 Million Stock Repurchase Program
Press releaseMay 7, 6:30 AM ETBusiness Wire
InfuSystem Announces Financial Results for First Quarter 2026
Press releaseApr 30, 6:30 AM ETBusiness Wire
InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026
Press releaseMar 16, 4:30 PM ETBusiness Wire
InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026
NewsFeb 24, 6:32 AM ET
InfuSystems Holdings Q4 Earnings Assessment
Press releaseFeb 24, 6:30 AM ETBusiness Wire
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
NewsFeb 24, 6:11 AM ET
Earnings Scheduled For February 24, 2026
Press releaseFeb 17, 6:30 AM ETBusiness Wire
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Press releaseDec 10, 5:37 PM ETBusiness Wire
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
Press releaseNov 10, 4:30 PM ETBusiness Wire
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
NewsNov 4, 6:30 AM ET
InfuSystems Holdings Q3 EPS $0.11 Beats $0.07 Estimate, Sales $36.488M Miss $36.806M Estimate
Press releaseNov 4, 6:30 AM ETBusiness Wire
InfuSystem Reports Third Quarter 2025 Financial Results
Press releaseOct 28, 4:30 PM ETBusiness Wire
InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025
Press releaseSep 25, 4:29 PM ETBusiness Wire
InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025
Press releaseAug 5, 6:30 AM ETBusiness Wire
InfuSystem Reports Second Quarter 2025 Financial Results
NewsAug 5, 4:32 AM ET
Earnings Scheduled For August 5, 2025
Press releaseJul 29, 4:30 PM ETBusiness Wire
InfuSystem to Report Second Quarter 2025 Financial Results on August 5, 2025
Press releaseMay 8, 6:30 AM ETBusiness Wire
InfuSystem Reports First Quarter 2025 Financial Results
NewsMay 8, 4:33 AM ET
Earnings Scheduled For May 8, 2025
NewsMay 7, 1:09 PM ET
InfuSystems Holdings's Earnings Outlook
Press releaseMay 1, 6:30 AM ETBusiness Wire
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
Press releaseApr 1, 6:30 AM ETBusiness Wire
InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer
Press releaseMar 4, 6:30 AM ETBusiness Wire
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
Press releaseFeb 25, 6:30 AM ETBusiness Wire
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Press releaseNov 22, 6:30 AM ETBusiness Wire
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
Press releaseNov 18, 9:15 AM ETBusiness Wire
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
Press releaseNov 7, 6:30 AM ETBusiness Wire
InfuSystem Reports Third Quarter 2024 Financial Results
Press releaseOct 31, 6:30 AM ETBusiness Wire
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
Press releaseSep 11, 6:30 AM ETBusiness Wire
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
Press releaseSep 11, 6:30 AM ETGlobe Newswire
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

InfuSystem to Host Investor Webcast on September 24, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

InfuSystems Holdings Reports Q2 2026 Results: Full Earnings Call Transcript

InfuSystems Holdings Q2 EPS $0.15 Beats $0.11 Estimate, Sales $36.933M Beat $36.353M Estimate

InfuSystem Announces Financial Results for Second Quarter 2026

InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026

InfuSystem Announces $20 Million Stock Repurchase Program

InfuSystem Announces Financial Results for First Quarter 2026

InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026

InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026

InfuSystems Holdings Q4 Earnings Assessment

InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025

Earnings Scheduled For February 24, 2026

InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025

InfuSystems Holdings Q3 EPS $0.11 Beats $0.07 Estimate, Sales $36.488M Miss $36.806M Estimate

InfuSystem Reports Third Quarter 2025 Financial Results

InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025

InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025

InfuSystem Reports Second Quarter 2025 Financial Results

Earnings Scheduled For August 5, 2025

InfuSystem to Report Second Quarter 2025 Financial Results on August 5, 2025

InfuSystem Reports First Quarter 2025 Financial Results

Earnings Scheduled For May 8, 2025

InfuSystems Holdings's Earnings Outlook

InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025

InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024

InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024

InfuSystem Appoints Ronald Hundzinski to the Board of Directors

InfuSystem Reports Third Quarter 2024 Financial Results

InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024

InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC